What are the treatment options for locally advanced Multiple Myeloma

Treatment Options for Locally Advanced Multiple Myeloma

I appreciate your question about locally advanced myeloma. Let me clarify an important point about myeloma classification, then explain your treatment options.

Understanding Myeloma Staging

Multiple myeloma is typically classified by risk level (standard risk vs. high risk) rather than "locally advanced" in the traditional sense. However, if you're asking about myeloma that has progressed beyond early stages or involves significant bone damage, here's what you should know:

According to NCCN Guidelines for Multiple Myeloma (2025), the primary treatment approach for active symptomatic myeloma—regardless of extent—involves multi-drug combination therapy.

---

Primary Treatment Options

Multi-Drug Combinations (First-Line Treatment)

The NCCN Guidelines recommend preferred multi-drug combinations that typically include 3-4 medications working together:

If you're a candidate for hematopoietic cell transplant:

• Daratumumab + bortezomib + lenalidomide + dexamethasone
• Bortezomib + lenalidomide + dexamethasone
• Carfilzomib + lenalidomide + dexamethasone

If you're NOT a candidate for transplant:

• Daratumumab + lenalidomide + dexamethasone
• Isatuximab-irfc + bortezomib + lenalidomide + dexamethasone
• Carfilzomib + lenalidomide + dexamethasone

Types of Medications in These Combinations

These combinations typically include:

1. Targeted Therapy (Proteasome Inhibitors)

   • Bortezomib (Velcade) or Carfilzomib (Kyprolis)
   • These block proteins that allow myeloma cells to survive

2. Immunomodulators

   • Lenalidomide (Revlimid) or Pomalidomide (Pomalyst)
   • These enhance your immune system's ability to fight cancer

3. Monoclonal Antibodies

   • Daratumumab (Darzalex) or Isatuximab-irfc (Sarclisa)
   • These are artificial antibodies that attach to myeloma cells and signal your immune system to attack them

4. Corticosteroids

   • Dexamethasone (Decadron)
   • Reduces inflammation and helps kill cancer cells

---

Hematopoietic Cell Transplant (HCT)

According to NCCN Guidelines, hematopoietic cell transplant is a major treatment option for eligible patients with active myeloma. Here's what this involves:

What it is: High-dose chemotherapy followed by infusion of your own healthy blood stem cells to rebuild your bone marrow

Timing: Usually performed after 4-6 cycles of initial treatment, when myeloma cell numbers are low

Eligibility: Your care team will assess factors including:

• Your overall fitness level and health status
• Organ function (heart, lungs, kidneys)
• Age (advanced age is NOT a contraindication)
• Your goals and preferences

Important note: Renal dysfunction and advanced age are not contraindications to transplant according to NCCN Guidelines.

---

Supportive Care (Essential Component)

Regardless of which treatment you receive, NCCN Guidelines emphasize bone-building therapy and symptom management:

• Bisphosphonates or denosumab - strengthen bones and prevent fractures (very common in myeloma)
• Radiation therapy - for localized bone pain
• Blood thinners - if medications increase clot risk
• Management of kidney function, infections, and anemia

---

How Treatment Response is Monitored

Your care team will use follow-up tests to determine if treatment is working:

• Blood tests (M protein levels, free light chains, CBC)
• Urine tests
• Imaging (PET/CT, MRI, or low-dose CT scans)
• Tests every 3 months initially

Treatment response means measurable improvement in myeloma markers and symptoms. This response helps determine your next steps—whether you're ready for transplant or maintenance therapy.

---

Key Questions to Ask Your Care Team

1. Which drug combination do you recommend for my specific situation, and why?
2. Am I a candidate for hematopoietic cell transplant? What factors will you consider?
3. What are the specific side effects I should expect with my treatment plan?
4. How often will we monitor my response, and what tests will you use?
5. If my myeloma doesn't respond to this treatment, what are my next options?
6. What supportive care (bone protection, symptom management) will I receive?
7. Are there clinical trials available for my situation?

---

Important Context

According to NCCN Guidelines, multiple myeloma cannot currently be cured, but new treatments are giving people more hope and more years to live. For many people, myeloma has become a chronic condition they can live with for extended periods.

The specific treatment recommended for YOUR situation depends on:

• Your risk factors (genetic markers like FISH results)
• Your overall health and organ function
• Whether you're transplant-eligible
• Your personal goals and preferences

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.